Home Stock

Stock Research: SCI Pharmtech

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

SCI Pharmtech

TAI:4119 TW0004119003
45
  • Value
    60
  • Growth
    84
  • Safety
    Safety
    52
  • Combined
    81
  • Sentiment
    19
  • 360° View
    360° View
    45
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

SCI Pharmtech, Inc. is a Taiwan-based company focused on manufacturing and selling Active Pharmaceutical Ingredients (APIs). The company operates in the pharmaceutical industry, producing APIs, API intermediates, and special chemicals. It distributes its products in Taiwan, Europe, the Americas, and other parts of Asia. In the last fiscal year, the company had a market cap of $254 million, profits of $13 million, and revenue of $46 million. The number of employees is not available.

more
Strongest Rank Market Pulse
Weakest Rank Profit Growth
Country Taiwan
Industry Pharmaceuticals
Size Small
Website sci-pharmtech.com.tw
Index
SCI Pharmtech stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
60 22 16 35
Growth
84 74 97 83
Safety
Safety
52 27 51 88
Sentiment
19 8 20 37
360° View
360° View
45 7 36 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
14 12 25 28
Opinions Change
50 50 50 50
Pro Holdings
n/a 32 38 55
Market Pulse
1 1 1 n/a
Sentiment
19 8 20 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
60 22 16 35
Growth
84 74 97 83
Safety Safety
52 27 51 88
Combined
81 27 56 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
23 18 9 20
Price vs. Earnings (P/E)
23 14 42 20
Price vs. Book (P/B)
69 31 29 48
Dividend Yield
89 44 21 75
Value
60 22 16 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
89 94 49 83
Profit Growth
91 70 100 23
Capital Growth
77 18 95 84
Stock Returns
9 56 71 65
Growth
84 74 97 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
54 41 55 96
Refinancing
18 24 21 35
Liquidity
74 49 78 100
Safety Safety
52 27 51 88

Similar Stocks

Discover high‑ranked alternatives to SCI Pharmtech and broaden your portfolio horizons.

Mitsubishi HC Capital

TYO:8593
Country: Japan
Industry: Specialized Finance
Size: X-Large
Full Stock Analysis

Astellas Pharma

TYO:4503
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Wistron

TAI:3231
Country: Taiwan
Industry: Technology Hardware & Peripherals
Size: Large
Full Stock Analysis

Simplo Technology

TWO:6121
Country: Taiwan
Industry: Electronic Components
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews